Currently, the emergence of artificial intelligence (AI) is revolutionizing medicine in general, and it is essential to be informed about the different options that the use of these artificial tools allows us, such as Machine Learning (ML) ChatGPT, Bard, and others.

Objetivo: Determinar los factores asociados a la no utilización de servicios de salud en una muestra de la población de lesbianas, gais, bisexuales, transgénero e intersexuales (LGBTI) de Perú. Materiales y métodos: Estudio transversal analítico, análisis de datos secundarios de la Primera Encuesta LGBTI de Perú. Se tomó como variable de interés a las personas que tuvieron alguna enfermedad durante los últimos doce meses y que tuvieron que recibir atención médica. Se calcularon razones de prevalencias crudas (RPc) y ajustadas (RPa), con intervalos de confianza al 95% (IC 95%), usando regresiones de Poisson con varianza robusta. Se desarrollaron tres modelos, ajustados a variables agrupadas en correspondencia con la orientación sexual, identidad de género e intersexualidad, respectivamente. Resultados: El 55,4% fueron registrados como varones al nacer, la mediana de la edad...

Background Maternal mortality remains a significant public health issue in low- and middle-income countries (LMICs), with high incidence rates in Latin America and the Caribbean (LAC). While maternal mortality decreased by nearly 45% between 1990 and 2015, regional inequalities persist. This study assesses maternal mortality trends in LAC women from 1997 to 2019, providing key insights to address this issue. Methods An ecological observational time-series study was conducted using data from the WHO Mortality Database for 18 countries in Latin America and the Caribbean between 1997 and 2019, focusing on women aged 15–49 years. Age-standardized maternal mortality rates (ASMR) per 100,000 person-years were estimated using the direct method, based on the SEGI world standard population. The MMR, defined as maternal deaths per 100,000 live births, was calculated using data from the Pan Ameri...

Background Diarrhea remains a major cause of preventable mortality in Latin American and Caribbean (LAC) countries, particularly among children and vulnerable populations. However, there are no studies showing the changes that have occurred in recent years in developing countries. Our objective was to determine the evolution of diarrhea mortality rates in LAC countries between 2000 and 2019. Methods An ecological observational time series study was conducted using only countries with complete population-based data in the World Health Organization mortality database between 2000 and 2019 with diarrhea mortality. Analyses were performed using Joinpoint Regression software to calculate mortality trends and annual percentage change by sex and by country. A mortality rates analysis of the last 5 years of the study period was performed to assess the countries with the highest rates. Results Be...

Background Stroke is a leading cause of death and disability globally, with significant public health implications. In Latin America, while mortality rates have declined, the number of stroke cases has increased due to prevalent risk factors like high blood pressure and obesity. Unlike Europe, recent trends in stroke mortality in this region remain underreported. Objective This study evaluates stroke mortality rates in Latin America Latin American and Caribbean (LAC) countries from 1997 to 2020 and predictions to 2035. Methods This ecological observational study utilized mortality data from the World Health Organization database. Trends were analyzed using Joinpoint regression to evaluate the annual percent change (APC) by sex and country. Predicted mortality rates through 2035 were calculated using the Nordpred package in R. Changes in stroke mortality were assessed by disentangling the...

Latin America has reported a 9% increase in new HIV infections from 2010 to 2023. Pre-exposure prophylaxis (PrEP) is a crucial biomedical intervention for preventing HIV transmission. Currently, several antiretroviral drugs, in various forms of administration, have demonstrated high efficacy and effectiveness to protect against HIV. Among the oral drugs, we have emtricitabine/te-nofovir and emtricitabine/tenofovir alafenamide, while alternative options include the dapivirine vaginal ring, injectable drugs such as Cabotegravir, and the most recently studied Lenacapavir. Despite their high efficacy and effectiveness, implementing PrEP in Latin America has been challenging throughout the region. Although some countries such as Brazil, Mexico, and Colombia have shown progress in increasing the number of users, there is a significant gap between these countries and others where PrEP access re...